Mimosa Therapeutics A Public Benefit
Alameda, US · Founded 2020 · Delaware corporation
Founders & leadership
JK
James KeimNamed on SEC filing
RS
Robert StanleyNamed on SEC filing
SA
Stephen ApkonNamed on SEC filing
AF
Amanda FeildingNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.3M disclosed across 2 rounds · 2021
▶$400KraisedJul 2021 · 5 investors · Other Health Care
▶$400KraisedJul 2021 · 5 investors · Other Health Care
Officers, directors & promoters on the filing
- James KeimExecutive Officer, Director, Promoter
- Robert StanleyDirector
- Stephen ApkonDirector
- Amanda FeildingDirector
- Offering amount
- $400K
- Amount sold
- $400K
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 04
▶$865KraisedFeb 2021 · 4 investors · Other Health CareRule 506(b)
▶$865KraisedFeb 2021 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Amanda FeildingDirector
- Robert StanleyDirector
- James KeimExecutive Officer, Director, Promoter
- Stephen ApkonDirector
- Offering amount
- $1.7M
- Amount sold
- $865K
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Mimosa Therapeutics A Public Benefit raised?
- Mimosa Therapeutics A Public Benefit has disclosed $1.3M raised across 2 rounds.
- Where is Mimosa Therapeutics A Public Benefit headquartered?
- Mimosa Therapeutics A Public Benefit is headquartered in Alameda, US.